Food and Drug Administration (FDA) Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A New Oral CLL and SLL Treatment: What Could It Mean for Patients?
The Food and Drug Administration (FDA) recently approved idelalisib (Zydelig), a new oral inhibitor therapy to treat CLL and SLL. Patients now have another option that may spare them the need for chem... Author: patientpower Added: 08/01/2014 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2014 Category: Cancer & Oncology Source Type: podcasts

Women's Health: Bio-Identical Hormone Replacement Therapy
Both the Food and Drug Administration as well as physicians question the claims made regarding the safety and effectiveness of bio-identical hormone replacement therapy. (Source: MUSC Women's Health Podcast)
Source: MUSC Women's Health Podcast - April 5, 2014 Category: Primary Care Authors: Medical University of South Carolina Source Type: podcasts

What Could New and Promising Treatment Options Mean for CLL Patients?
A new treatment, ibrutinib (Imbruvica), was recently approved by the Food and Drug Administration (FDA) for use in CLL patients who have received at least one previous therapy. Dr. Susan O'Brien, a le... Author: patientpower Added: 02/19/2014 (Source: Oncology Tube)
Source: Oncology Tube - February 20, 2014 Category: Cancer & Oncology Source Type: podcasts

BMJ podcast - high risk devices for rare conditions
Two articles on bmj.com look at high risk devices for rare conditions, and how the US Food and Drug Administration regulates them. Joining us to discuss the problems are Rita Redberg, professor of medicine at the University of California San Francisco, and Aaron Kesselheim, assistant professor of medicine at the Harvard School of Public health. Read the articles Presumed safe no more: lessons from the Wingspan saga on regulation of devices http://www.bmj.com/content/348/bmj.g93 Assessment of US pathway for approving medical devices for rare conditions http://www.bmj.com/content/348/bmj.g217 (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 24, 2014 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Regulation, regulation, regulation
A BMJ investigation this week raises concerns about the ability of the US Food and Drug Administration to monitor the safety of medical devices through post-approval surveillance. We ask: is the FDA giving device manufacturers an easy regulatory ride? Also, the National Institute for Health and Clinical Excellence (NICE) is set to lose the power... (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 28, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts

Regulation, regulation, regulation
A BMJ investigation this week raises concerns about the ability of the US Food and Drug Administration to monitor the safety of medical devices through post-approval surveillance. We ask: is the FDA giving device manufacturers an easy regulatory ride? Also, the National Institute for Health and Clinical Excellence (NICE) is set to lose the power to restrict the use of any drug that exceeds its £30k cost per quality adjusted life year ceiling. Alan Maynard, professor of health economics at the University of York, discusses what this will mean. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 28, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts

" Vision Realized " -- The Discovery Files
The U.S. Food and Drug Administration has granted market approval to an artificial retina technology, the first bionic eye to be approved for patients in the U.S. (Source: The Discovery Files)
Source: The Discovery Files - February 21, 2013 Category: Science Authors: National Science Foundation Source Type: podcasts

Duration of Bisphosphonate Use and the US Food and Drug Administration
What does the recent US FDA vote regarding the need to clarify duration of bisphosphonate treatment mean for your patients? Dr. Andrew Kaunitz offers his recommendations. (Source: Medscape Orthopaedics Podcast)
Source: Medscape Orthopaedics Podcast - September 22, 2011 Category: Orthopaedics Authors: Medscape Source Type: podcasts

Are You Prescribing Unapproved Drugs?
Some drugs that are currently on the market have never been approved by the US Food and Drug Administration (FDA). (Source: Medscape Anesthesiology Podcast)
Source: Medscape Anesthesiology Podcast - March 3, 2011 Category: Anesthesiology Authors: Medscape Source Type: podcasts

Are You Prescribing Unapproved Drugs?
Some drugs that are currently on the market have never been approved by the US Food and Drug Administration (FDA). (Source: Medscape Dermatology Podcast)
Source: Medscape Dermatology Podcast - March 3, 2011 Category: Dermatology Authors: Medscape Source Type: podcasts

FDA Commissioner: 'Safety Science' Key to Drug Regulation
Dr. Margaret Hamburg talks with Dr. Eli Adashi about the complex role of the US Food and Drug Administration in approving new drugs while still ensuring their safety. (Source: Medscape Dermatology Podcast)
Source: Medscape Dermatology Podcast - February 2, 2011 Category: Dermatology Authors: Medscape Source Type: podcasts

FDA Commissioner: 'Safety Science' Key to Drug Regulation
Dr. Margaret Hamburg talks with Dr. Eli Adashi about the complex role of the US Food and Drug Administration in approving new drugs while still ensuring their safety. (Source: Medscape Anesthesiology Podcast)
Source: Medscape Anesthesiology Podcast - February 2, 2011 Category: Anesthesiology Authors: Medscape Source Type: podcasts